ADA and HIV-1 infection: This difference in infection efficiency between T/F WITO and HIV ADA may be linked to the differential impact of host antiviral restriction factors and notably interferon-induced transmembrane proteins (IFTIMs), which accumulate intracellularly during HIV-1 infection of macrophages (56, 57) and are incorporated into virions, thus reducing their infectivity (57).